Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
35.4M
-
Shares change
-
+1.59M
-
Total reported value, excl. options
-
$265M
-
Value change
-
+$11.4M
-
Put/Call ratio
-
3.22
-
Number of buys
-
56
-
Number of sells
-
-40
-
Price
-
$7.49
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q1 2025
130 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q1 2025.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
of 53.4M outstanding shares and own 66.16% of the company stock.
Largest 10 shareholders include Woodline Partners LP (4.62M shares), BlackRock, Inc. (4.13M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.62M shares), VANGUARD GROUP INC (2.83M shares), FMR LLC (2.31M shares), Nantahala Capital Management, LLC (1.47M shares), AIGH Capital Management LLC (1.44M shares), Altium Capital Management LLC (1.29M shares), GEODE CAPITAL MANAGEMENT, LLC (1.23M shares), and 683 Capital Management, LLC (1.23M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.